Erratum: Adverse drug reactions of imatinib in patients with chronic myeloid leukemia: A single-center surveillance study: Erratum.

[This corrects the article on p. 30 in vol. 6, PMID: 25709349.].

In the article, “Adverse drug reactions of imatinib in patients with chronic myeloid leukemia: A single-center surveillance study”, which appeared in vol. 6, issue 1, pages 30-33 of Journal of Pharmacology and Pharmacotherapeutics,[1] the abbreviation in Table 1, at page 31, is incorrectly written as CTACE instead of CTCAE for the expansion of Common Terminology Criteria for Adverse Events.

This has now been corrected and reposted online.